We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Improper Anticoagulant Therapy Increases Bleeding Risk

By HospiMedica International staff writers
Posted on 12 Mar 2019
A new study reveals that many patients receiving warfarin for the management of atrial fibrillation (AF) or venous thromboembolism (VTE) also take aspirin without a clear therapeutic indication.

Researchers at the University of Michigan (U-M; Ann Arbor, USA), Huron Valley Sinai Hospital (Commerce Township, MI, USA), and other institutions conducted a registry-based cohort study involving 6,539 adults (50.9% men) at six anticoagulation clinics in the state of Michigan receiving warfarin therapy for AF or VTE (without documentation of a recent myocardial infarction or history of valve replacement), in order to evaluate the frequency and outcomes of combination anticoagulation therapy without clear indication.

Of the study cohort, 2,453 patients (37.5%) who had no clear therapeutic indication for aspirin were receiving a combination warfarin and aspirin therapy. More...
Of these, 5.7% experienced major bleeding events after one year, compared to 3.3% of those on warfarin only. The combination therapy group was also hospitalized for bleeding significantly more often. However, there was no difference in stroke or heart attack outcomes at one year, and mortality rates were similar between both groups, at 2.3%. The study was published on March 4, 2019, in JAMA Internal Medicine.

“Nearly 2,500 patients who were prescribed warfarin were taking aspirin without any clear reason, over a seven-year period. No doctors really own the prescribing of aspirin, so it's possible it got overlooked,” said senior author vascular cardiologist Geoffrey Barnes, MD, MSc, of the U-M Medical School. “The combination does make sense for a small number of people; patients who may need to be on both medications include those who have had a recent heart attack, recent coronary stent placement, or bypass surgery, prior mechanical valve surgery, or known peripheral artery disease.”

“Clinicians should ask their patients who are anticoagulated with warfarin if they're taking aspirin as well. For the patients who are on both therapies, clinicians should review their medical history to determine if it's really necessary to be on both drugs,” said lead author hematologist Jordan Schaefer, MD, of M-U Medicine. “There's been some hint of this being an issue for a long time. Now, based on these new findings, we're working to reduce the number of patients on aspirin without a clear reason for both drugs.”

Aspirin (acetylsalicylic acid) is a salicylate drug often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin's efficacy as an anticlotting agent and its widespread use as a preventive treatment for heart attacks and strokes have turned it into one of the most widely used medications in the world, with an estimated 40,000 tons of it being consumed each year.

Related Links:
University of Michigan
Huron Valley Sinai Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gold Member
Blood Gas Analyzer
i-Check200
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.